Immunomodulatory treatment in postural tachycardia syndrome: A case series,European Journal of Neurology

当前位置： X-MOL 学术 › Eur. J. Neurol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Immunomodulatory treatment in postural tachycardia syndrome: A case series
European Journal of Neurology ( IF 4.5 ) Pub Date : 2020-12-31 , DOI: 10.1111/ene.14711
Belén Rodriguez ₁ , Robert Hoepner ₂ , Anke Salmen ₂ , Nicole Kamber ₂ , Werner J Z'Graggen _{1,

2}

Affiliation

Postural tachycardia syndrome (POTS) is a form of autonomic dysfunction characterized by symptoms of orthostatic intolerance, often accompanied by sudomotor dysfunction and gastrointestinal dysmotility. Recently, evidence has accumulated that in a subset of patients, the pathogenesis of dysautonomia may be immune‐mediated. The aim of the current report was to evaluate the use of intravenous immunoglobulin (IVIG) treatment in patients with progressive and/or refractory immune‐mediated POTS.

中文翻译：

体位性心动过速综合征的免疫调节治疗：病例系列

姿势性心动过速综合征 (POTS) 是一种以直立性不耐受症状为特征的自主神经功能障碍，通常伴有排汗功能障碍和胃肠动力障碍。最近，越来越多的证据表明，在一部分患者中，自主神经功能障碍的发病机制可能是免疫介导的。本报告的目的是评估静脉注射免疫球蛋白 (IVIG) 治疗在进行性和/或难治性免疫介导的 POTS 患者中的应用。

更新日期：2020-12-31

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11